CRBU Caribou Biosciences, Inc.
$1.27▼ -7.30%
Healthcare
Other
After hours
$1.29▲ +1.57%
Sep 11, 7:55 PM ET
Volume 2.42M
Avg Volume (10D) 1.05M
Key Metrics & Fundamentals
Market Cap
$136.15M
P/E Ratio
–
Div Yield
–%
52W Range
1.26 - 3.54
% vs 50 MA
-22.22%
% vs 200 MA
-28.79%
RSI-14
27.5
MACD Histogram
-0.0300
Beta (1Y vs SPY)
2.28
Free Cash Flow
-$22.79M
Gross Rev
$1.50M
Gross Profit
$1.50M
EBITDA
-$24.71M
COGS
–
Operating Exp
$26.84M
Operating Income
-$25.34M
EBIT
-$25.34M
Pretax Income
-$24.28M
Net Income
-$24.28M
EPS (Diluted)
-0.24
Price & Volume History
Loading chart…
Recent News
BofA Adjusts Price Target on Caribou Biosciences to $5 From $6
MT Newswires · Aug 14, 2026 11:46 AM
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 13, 2026 10:05 PM
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 13, 2026 8:05 PM
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 6, 2026 12:20 PM
Vir Biotechnology, Inc. (VIR) Q2 Earnings and Revenues Miss Estimates
Zacks · Aug 6, 2026 12:35 AM
BMS and Gilead rule in the CAR-T space. Off-the-shelf developers aren’t trying to change that.
Pharma Voice · Jul 29, 2026 9:49 AM
Are Medical Stocks Lagging Caribou Biosciences (CRBU) This Year?
Zacks · Jul 9, 2026 1:40 PM
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
GlobeNewswire · Jun 29, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CRBU's money flow as a full page
Social Sentiment
No Reddit posts found for CRBU.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.